User profiles for "author:Emma Wall"
Emma WallFrancis Crick Institute; University College London Verified email at crick.ac.uk Cited by 2489 |
Community-acquired bacterial meningitis
Progress has been made in the prevention and treatment of community-acquired bacterial
meningitis during the past three decades but the burden of the disease remains high …
meningitis during the past three decades but the burden of the disease remains high …
Neutralising antibody activity against SARS-CoV-2 VOCs B. 1.617. 2 and B. 1.351 by BNT162b2 vaccination
that emerged in the UK with the second COVID-19 wave in late 2020. The efficacy of
currently licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses …
currently licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses …
[HTML][HTML] Acute bacterial meningitis
Acute bacterial meningitis : Current Opinion in Neurology Acute bacterial meningitis :
Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new …
Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new …
[HTML][HTML] Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Abstract Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
The SARS-CoV-2 B. 1.617. 2 Delta variant of concern (VOC) continues to drive a sharp
increase in COVID-19 cases in the UK, with a current doubling time of 3· 5–16 days, 1 …
increase in COVID-19 cases in the UK, with a current doubling time of 3· 5–16 days, 1 …
Osmotic therapies added to antibiotics for acute bacterial meningitis
ECB Wall, KMB Ajdukiewicz… - Cochrane Database …, 2018 - cochranelibrary.com
Background Every day children and adults die from acute community‐acquired bacterial
meningitis, particularly in low‐income countries, and survivors risk deafness, epilepsy and …
meningitis, particularly in low‐income countries, and survivors risk deafness, epilepsy and …
Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda
N Longley, C Muzoora, K Taseera… - Clinical infectious …, 2008 - academic.oup.com
Background. Therapy for human immunodeficiency virus (HIV)–associated cryptococcal
meningitis in many centers in Africa is fluconazole administered at a dosage of 400–800 mg …
meningitis in many centers in Africa is fluconazole administered at a dosage of 400–800 mg …
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients
We sought to compare neutralising antibody responses between seronaive haemodialysis
patients and the healthy individuals we have already reported on as part of the Legacy …
patients and the healthy individuals we have already reported on as part of the Legacy …
[HTML][HTML] Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
Patients with cancer are at greater risk of severe COVID-19 and have been prioritised for
COVID-19 vaccination globally. We previously showed that following two doses of COVID …
COVID-19 vaccination globally. We previously showed that following two doses of COVID …
[PDF][PDF] Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
Patients with cancer are at higher risk of severe COVID-19 (Grivas et al., 2021; Kuderer et
al., 2020), and they are currently prioritized globally for a third COVID-19 vaccine dose …
al., 2020), and they are currently prioritized globally for a third COVID-19 vaccine dose …